Centers of Excellence in Specialty Tops SPT Week in Review

Article

Top news of the week from Specialty Pharmacy Times.

5. First Short-Course Oral Therapy Approved for Relapsing Forms of MS

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment. Read more.

4. Gilteritinib Prolongs Survival in Patients with FLT3-Mutated AML

Gilteritinib (Xospata) was superior to standard chemotherapy in improving overall survival in patients with acute myeloid leukemia. Read more.

3. FDA Approves Novel Intravenous Immune Globulin

Immune Globulin Intravenous, Human — slra 10% Liquid (Asceniv) is indicated for use in the treatment of primary humoral immunodeficiency disease in adults and adolescents. Read more.

2. Medicaid Coverage of Recommended Lung Cancer Screenings Varies Across States

Although lung cancer screenings are covered at no cost by most insurers, state Medicaid programs are not required to offer coverage for this service. Read more.

1. A Step by Step Guide to Establishing and Maintaining a Special Center of Excellence

Specialty pharmacy can benefit from having definitive a center of excellence model that caters to respective therapies and disease states. Read more.

Related Videos
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.